Vetoquinol (XPAR:VETO) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAR:VETO Vetoquinol SA XPAR:VETO
94 GF Score
Price €71.70
GF Value €85.39
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Vetoquinol FFO?

FFO (Funds from operations) only applies to REITs.

XPAR:VETO
94GF Score
Vetoquinol SA XPAR:VETO
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Vetoquinol (XPAR:VETO) Overvalued in 2026?

Based on GuruFocus' analysis, Vetoquinol stock appears to be undervalued. The current stock price of €71.70 is trading 16% below its estimated GF Value™ of €85.39. GuruFocus considers Vetoquinol to be Modestly Undervalued.

Key valuation signals for XPAR:VETO:

  • FFO:
  • GF Value™: €85.39 vs. price of €71.70 (16% below fair value)
  • GF Score™: 94/100 with 1 warning sign

No single metric tells the full story. See the XPAR:VETO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vetoquinol Business Description

Other Exchanges 0O1O:UK8JM:Germany
Address Magny-Vernois, BP 189, Lure cedex, FRA, 70204
Vetoquinol SA operates is a France-based firm serving in the healthcare market. Its focus lies on developing and marketing veterinary drugs mainly in the European region and to a certain extent in America and Asia. Its portfolio of drugs entails anti-infectives, anti- pain inflammatory drugs, cardiovascular and nephrology treatment intended mainly for pets and livestock.
94GF Score

Get the complete analysis for XPAR:VETO

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€71.70
Price
€85.39
GF Value